Can Pulsed Electromagnetic Fields Trigger On-Demand Drug Release from High-Tm Magnetoliposomes?

Area of Science:

• Biomedical Engineering
• Materials Science
• Drug Delivery Systems

Background:

• Magnetic nanoparticles (MNPs) enable magneto-nanomechanical drug release from magnetoliposomes by enhancing membrane permeability.
• Non-thermal alternating magnetic fields (AMFs) are effective but have limited clinical applications.
• Pulsed electromagnetic fields (PEMFS) offer an alternative non-thermal magnetic field modality.

Purpose of the Study:

• To investigate the efficacy of non-thermal PEMFS in triggering drug release from high-transition temperature magnetoliposomes (high-Tm MLs).
• To assess the impact of PEMFS on liposome integrity and drug release kinetics for hydrophilic model drugs.

Main Methods:

• High-Tm MLs were fabricated by combining hydrophilic MNPs with hydrogenated soybean phosphatidylcholine and cholesterol.
• The release of a hydrophilic dye model drug from the high-Tm MLs was evaluated under PEMF exposure.
• Liposome integrity was assessed post-PEMF treatment.

Main Results:

• PEMFS effectively induced motion of MNPs within the liposomes, increasing bilayer permeability.
• Drug release was achieved without compromising the structural integrity of the magnetoliposomes.
• Approximately 20% of the hydrophilic model drug was released after 3 hours of PEMF exposure.

Conclusions:

• PEMFS represent a viable non-thermal method for triggering drug release from magnetoliposomes.
• This approach offers a proof-of-concept for utilizing PEMFS in drug delivery systems.
• The established therapeutic applications of PEMFS suggest potential for integrating this drug release method into clinical practice.